Boston Scientific Corporation (NYSE: BSX) reported Q4 EPS of $0.20, $0.10 better than the analyst estimate of $0.10. Revenue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE